Artificial intelligence (AI) technologies are profoundly reshaping the healthcare industry by revolutionising diagnostics and personalizing treatment plans. This transformation is driven by the development of sophisticated algorithms, machine learning models, and advanced data analytics, which facilitate more accurate, efficient, and tailored medical care. AI’s strength lies in its predictive analytics capabilities, which are essential for early disease detection and prevention, enhancing the precision and timeliness of medical interventions.
Healthcare providers frequently create a significant volume of patient information and heterogeneous data.Thus, it is difficult for the “conventional techniques” to analyse, manage and extract patterns from medical datasets. AI facilitates effective analysis of this data for practical insights. Additionally, various data sources, including genetics, medical reports, biospecimens, medical images, among others can be used to supplement healthcare data.
Prognosis, diagnosis, therapy, and clinical workflow are the four main aspects of healthcare that can be benefited through AI approaches. The models are often referred as Computer-Aided Diagnostics (CADx). These CADx models support healthcare professionals to interpret different medical data sources such as bio-signals, medical images/videos, health reports and genetic sequences for extracting typical patterns. These patterns further highlight the noticeable abnormalities, such as probable diseases, to offer input to support a decision taken by the professional.
By analyzing data from various sources, AI can identify risk factors and predict the likelihood of diseases developing in patients. Healthcare providers or companies now use AI to advance precision medicine through the analysis of clinical and molecular data. Their platform helps in predicting patient outcomes and determining the most effective treatment plans. By analyzing genetic information and health records, the company predicts likelihood of cancer recurrence in patients and recommend personalized follow-up care.
Another significant impact of AI in diagnostics is its ability to enhance the accuracy and speed of identifying diseases. Traditional diagnostic methods often rely on human expertise, which can be time-consuming and prone to errors. AI technologies, however, can analyze vast amounts of data quickly and accurately. The healthcare players have started leveraging AI to analyze medical images, electronic health records, and genomic data to diagnose different disease conditions. The machine learning algorithms can identify patterns and anomalies that might be missed by human eyes, leading to earlier and more accurate diagnoses. For instance, Oncology models, developed by health-tech innovators help oncologists identify personalized treatment options for patients based on comprehensive data analysis. AI’s ability to process and analyze large datasets also enables the creation of highly personalized treatment plans. These plans are tailored to the individual characteristics of each patient, including their genetic makeup, lifestyle, and health history. Many healthcare companies utilize AI to analyze the genetic profiles of tumors. This information allows oncologists to select the most appropriate targeted therapies for cancer patients. By understanding the specific genetic mutations driving a patient’s cancer, companies can recommend treatments that are more likely to be effective, minimizing the trial-and-error approach often seen in oncology.
Along with personalized care, AI offers real-time monitoring of patients and the continuous adjustment of treatment plans based on new data. Wearable devices and remote monitoring tools collect data on patients’ health in real-time, which AI algorithms can analyze to provide immediate feedback and adjust treatments as needed. AI is now being used for real-time monitoring of chronic conditions such as diabetes. New model employs AI algorithms to predict glucose levels in diabetic patients and provide personalized insulin dosing recommendations. This real-time adjustment helps in maintaining optimal blood sugar levels and reducing the risk of complications.
As medical data is constantly emerging by digitalization of patient’s records, AI is accelerating the drug discovery and development process. Traditional methods of drug discovery are often slow and costly, but AI can streamline this process by predicting which drug formulations might be effective and identifying potential candidates more quickly.
The article is writtent by By Harpreet Singh, Director, Gilead Sciences.
(DISCLAIMER: The views expressed are solely of the author and ETHealthworld.com does not necessarily subscribe to it. ETHealthworld.com shall not be responsible for any damage caused to any person/organisation directly or indirectly)
